Close

Dr Katherine Gallagher

BSc MSc PhD

Assistant Professor
of Epidemiology

KEMRI-Wellcome Trust Research Programme
PO BOX 230
Kilifi Town
80108
Kenya

Tel.
020 79272849

My areas of interest are infectious disease epidemiology and vaccine research. I completed an MRC(UK)-funded PhD in 2016 that included studies to assess whether human papillomavirus (HPV) infection increased HIV acquisition in East African women, to evaluate HPV vaccine introduction in Tanzania and to collate 'lessons learnt' during HPV vaccine introduction in 46 low and middle-income countries. Whilst based at the Mwanza Intervention Trials Unit in Tanzania for 2014 and 2015, I also aided the initial set-up of the EBOVAC1 Ebola vaccine Phase 1 trial. As a post-doc, I worked as the London-based academic coordinator of the EBOVAC1 projects including two large phase 2b vaccine trials in Sierra Leone and 2 nested observational studies.  

Since July 2018 I have been based at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, setting up a trial to assess whether lower doses of the two currently available pneumococcal conjugate vaccines protect Kenyan infants as well as the full dose schedules. We will compare the immune response and carriage of the pneumococcus in the nose (a surrogate marker for disease) after vaccination with a full, 40% or 20% dose schedule. The results could be used to enable countries unable to afford the full cost of the vaccine, to continue delivering it in the childhood immunisation programme in the absence of Gavi support.

Affiliations

Department of Clinical Research
Faculty of Epidemiology and Population Health
Department of Infectious Disease Epidemiology

Centres

Centre for Evaluation
Centre for Maternal Adolescent Reproductive & Child Health (MARCH)
Vaccine Centre

Teaching

I am co-organiser of the distance learning Study Design module, and tutor on the Epidemiology of Communicable Disease module. I also conduct face-to-face teaching for the Design and Analysis of Epidemiological Studies module and the Epidemiological Evaluation of Vaccines short course.

Research

Research Area
Bacteria
Child health
Clinical trials
Health policy
Health systems
Public health
Sexual health
Vaccines
Adolescent health
Health workers
Disease control
Evaluation
Immunisation
Implementation research
Discipline
Epidemiology
Vaccinology
Disease and Health Conditions
HIV/AIDS
Infectious disease
Cervical cancer
Emerging Infectious Disease
Human papillomavirus (HPV)
Respiratory disease
Country
Kenya
Sierra Leone
Somalia
Tanzania
Uganda
Region
Sub-Saharan Africa (all income levels)

Selected Publications

The Predictive Performance of a Pneumonia Severity Score in Human Immunodeficiency Virus-negative Children Presenting to Hospital in 7 Low- and Middle-income Countries.
Gallagher KE; Knoll MD; Prosperi C; Baggett HC; Brooks WA; Feikin DR; Hammitt LL; Howie SRC; Kotloff KL; Levine OS
2019
Clinical Infectious Diseases
Status of HPV vaccine introduction and barriers to country uptake.
Gallagher KE; LaMontagne DS; Watson-Jones D
2018
Vaccine
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.
Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Griffiths UK; Feletto M; Burchett HED; LaMontagne DS; Watson-Jones D
2017
PloS one
The Association Between Cervical Human Papillomavirus Infection and Subsequent HIV Acquisition in Tanzanian and Ugandan Women: A Nested Case-Control Study.
Gallagher KE; Baisley K; Grosskurth H; Vallely A; Kapiga S; Vandepitte J; Kamali A; De Sanjosé S; Changalucha J; Hayes R
2016
The Journal of infectious diseases
Lessons learnt from human papillomavirus (HPV) vaccine demonstration projects and national programmes in low- and middle-income countries
Gallagher KE; Kabakama S; Howard N; Mounier-Jack S; Griffiths UK; Feletto M; Lamontagne DS; Burchett HED; Watson-Jones D
2016
Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review.
Gallagher KE; Kadokura E; Eckert LO; Miyake S; Mounier-Jack S; Aldea M; Ross DA; Watson-Jones D
2016
BMC public health
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.
Howard N; Mounier-Jack S; Gallagher KE; Kabakama S; Griffiths UK; Feletto M; LaMontagne DS; Burchett HED; Watson-Jones D
2016
Human vaccines & immunotherapeutics
See more Publications